How Social Stigma Dictates Women's Healthcare

Social stigma in women's healthcare has a number attached to it. Most people have never been shown it.

Here it is. In a study of 981 adults who came to an urban emergency department with acute abdominal pain, women waited a median of 65 minutes to get pain medication. Men waited 49. That is a 16-minute gap, published in Academic Emergency Medicine (PMID 18439195).

Same pain scores. Different wait.

You have probably been told at some point that you were being dramatic. Or sensitive. Or that it was stress.

That was not a read on you. It was a pattern, and the pattern has been counted. What follows is the count.

What does social stigma in women's healthcare actually look like?

It looks like being believed more slowly.

The 2008 emergency department study is the cleanest example. Of the 981 patients enrolled, 65% were women. Men and women reported similar mean pain scores. Women were still less likely to get any analgesia at all, 60% compared with 67%, and less likely to get opioids, 45% compared with 56%.

The researchers then controlled for age, race, triage class, and pain score. The gap held. Women remained 13% to 25% less likely to receive opioid pain relief.

"Gender bias is a possible explanation for oligoanalgesia in women who present to the ED with acute abdominal pain." — Chen et al., Academic Emergency Medicine, 2008 (PMID 18439195)

That is not a story about one bad doctor. It is a measured pattern across a whole department.

Why does "hysteria" still matter?

Because the reflex outlived the diagnosis.

The word comes from the Greek hystera, meaning uterus. For most of recorded medical history, symptoms in women that a physician could not explain got routed to an emotional cause rather than a physical one.

Nobody writes that diagnosis down anymore. The routing still happens.

The modern version is quieter. Your symptom is real, your test is normal, and the conversation slides toward anxiety before anyone has run the second test. That slide is what the 16-minute number is made of.

How long does a delayed diagnosis actually take?

For endometriosis, an average of 6.4 years.

A 2024 systematic review in Fertility and Sterility (PMID 38101562) opens with the scale of it: endometriosis affects 1 in 9 women and those assigned female at birth, and it takes 6.4 years to diagnose using the conventional standard of laparoscopy.

Read that as time, not as a statistic. 6.4 years of periods. 6.4 years of being told cramps are normal.

The review's whole argument is that better imaging could shorten the delay. Which means the delay was never a law of nature. It was a choice about what counts as worth investigating.

Where does the research gap come from?

From who gets enrolled in the first place.

An FDA analysis published in AIDS in 2023 (PMID 36728423) looked at 18 phase 3 HIV-1 trials submitted to the agency since 2010. It measured enrollment against how common the disease actually is in each group.

US women were enrolled at a participation-to-prevalence ratio of 0.59. For US Black women it was 0.63. A ratio between 0.8 and 1.2 is what fair representation looks like.

The authors also found statistically significant sex differences in efficacy outcomes, and noted that low female enrollment made those differences harder to detect at all.

So the evidence base itself is thinner for you. We wrote about what that does to dosing in dosed like a smaller man.

How does weight bias change the care you get?

It changes what the visit is about.

A review in Obesity Reviews (PMID 25752756) examined the evidence on weight bias among healthcare providers. Its finding: many providers hold strong negative attitudes and stereotypes about patients with obesity, and those attitudes influence judgment, interpersonal behavior, and decision-making.

"Experiences of or expectations for poor treatment may cause stress and avoidance of care, mistrust of doctors and poor adherence among patients with obesity." — Phelan et al., Obesity Reviews, 2015 (PMID 25752756)

The review is explicit that this can reduce quality of care even when the provider intends the opposite.

For women on GLP-1 medication, that bias arrives with a second layer, because the treatment itself is treated as a moral question rather than a medical one.

Which conversations get skipped most?

The ones that got labeled impolite.

Three come up over and over. Menstrual and pelvic pain, where "cramps are normal" delays the endometriosis workup by years. Weight and metabolic health, where the number on the scale absorbs the appointment. And perimenopause, where symptoms arrive with no announcement and often get filed under stress.

None of those are rare. All three are routinely left unsaid.

Silence is not modesty here. It is missing data in your own chart. If perimenopause is where you are, start with what happens to your gut at midlife.

What can you actually do in the exam room?

Three things, and they are all small.

Pivot back to the physical. If your pain gets attributed to stress, say the specific thing: "I hear that. I am here for the pelvic pain. What test rules out a physical cause?" You are not arguing. You are naming the next step.

Ask for it in the chart. If a test you asked for is declined, ask that the decline be documented. That single request changes how carefully the decision gets made.

Bring someone. A second person in the room hears what you miss and asks the question you talked yourself out of.

None of this should be your job. All of it works.

Where does Seya stand?

On the plain version of things.

Seya exists because most research studied men and most products were built on that research. We say bloat, constipation, and perimenopause out loud because euphemism is how a symptom gets dropped from a chart.

Our one product is a fiber gummy delivering about 5 grams of resistant tapioca fiber a day. At that amount the evidence supports regularity, and that is the only claim we make. We are not going to tell you a supplement fixes a system that keeps women waiting 16 extra minutes for pain relief. It does not.

3 vegan gummies. Ingredients you can name. If your pain, bleeding, or digestion changes suddenly, that is a doctor conversation, not a supplement one.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Related reading: why women's health is decades behind, why women get UTIs, our daily fiber gummy for women, and more from the Seya journal.

Frequently asked questions

Is medical gaslighting real, or does it just feel that way?

It has been measured. In a prospective study of 981 emergency department patients with acute abdominal pain, published in Academic Emergency Medicine in 2008, men and women reported similar mean pain scores, but women were less likely to receive any analgesia (60% versus 67%) and less likely to receive opioids (45% versus 56%).

Women also waited a median of 65 minutes for pain medication compared with 49 minutes for men, a 16-minute difference with a 95% confidence interval of 3.5 to 33 minutes. After controlling for age, race, triage class, and pain score, women remained 13% to 25% less likely to receive opioid analgesia. The authors named gender bias as a possible explanation.

How long does endometriosis take to diagnose?

An average of 6.4 years using the conventional standard of laparoscopy, according to a 2024 systematic review in Fertility and Sterility. The same review states that endometriosis affects 1 in 9 women and people assigned female at birth.

The delay is driven partly by how normal severe menstrual pain is assumed to be, which discourages both reporting and referral. The review argues that specialist transvaginal ultrasound and combination imaging can shorten that delay, so the wait reflects diagnostic practice rather than anything inherent to the disease.

Are women underrepresented in clinical trials?

Yes, and it is quantified. An FDA analysis published in AIDS in 2023 reviewed 18 phase 3 HIV-1 trials submitted to the agency since 2010 and calculated a participation-to-prevalence ratio, which compares the share of women in a trial with the share of women in the disease population.

A ratio between 0.8 and 1.2 indicates fair representation. US women came in at 0.59, and US Black women at 0.63. The analysis also found statistically significant sex differences in efficacy outcomes, and concluded that low enrollment of women limited the ability to detect such differences at all.

Does weight bias affect the quality of medical care?

The evidence says it does. A review in Obesity Reviews in 2015 found that many healthcare providers hold strong negative attitudes and stereotypes about patients with obesity, and that these attitudes influence person-perception, judgment, interpersonal behavior, and decision-making.

The review reports that experiences of or expectations for poor treatment can cause stress, avoidance of care, mistrust of doctors, and poor adherence among patients. It concludes that stigma can reduce quality of care despite providers' intentions to deliver good care, which is why it is a systems problem rather than an individual one.

Written and reviewed by the Seya Health Editorial Team. Every health claim on this page is sourced to primary research, as of July 2026.

Related reading

• How Much Fiber Do Women Actually Need? Grams by Age, and Why It's More Than You Think